Loss of Robustness and Addiction to IGF1 during Early Keratinocyte Transformation by Human Papilloma Virus 16 by Geiger, Tamar & Levitzki, Alexander
Loss of Robustness and Addiction to IGF1 during Early
Keratinocyte Transformation by Human Papilloma Virus
16
Tamar Geiger, Alexander Levitzki*
Unit of Cellular Signaling, Department of Biological Chemistry, The Alexander Silverman Institute of Life Sciences, The Hebrew University of Jerusalem,
Jerusalem, Israel
Infection of keratinocytes with high risk human Papilloma virus causes immortalization, and when followed by further
mutations, leads to cervical cancer and other anogenital tumors. Here we monitor the progressive loss of robustness in an in
vitro model of the early stages of transformation that comprises normal keratinocytes and progressive passages of HPV16
immortalized cells. As transformation progresses, the cells acquire higher proliferation rates and gain the ability to grow in soft
agar. Concurrently, the cells lose robustness, becoming more sensitive to serum starvation and DNA damage by Cisplatin. Loss
of robustness in the course of transformation correlates with significant reductions in the activities of the anti-apoptotic
proteins PKB/Akt, Erk, Jnk and p38 both under normal growth conditions and upon stress. In parallel, loss of robustness is
manifested by the shrinkage of the number of growth factors that can rescue starving cells from apoptosis, with the
emergence of dependence solely on IGF1. Treatment with IGF1 activates PKB/Akt and Jnk and through them inhibits p53,
rescuing the cells from starvation. We conclude that transformation in this model induces higher susceptibility of cells to stress
due to reduced anti-apoptotic signaling and hyper-activation of p53 upon stress.
Citation: Geiger T, Levitzki A (2007) Loss of Robustness and Addiction to IGF1 during Early Keratinocyte Transformation by Human Papilloma Virus
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INTRODUCTION
Cancer development is a multi-step process in which cells gain
high proliferation rates and resistance to apoptotic signals. In this
long process cells accumulate mutations and chromosomal
aberrations due to impaired cell cycle control and DNA repair
mechanisms. In the past few decades, thousands of research
projects have characterized tumor suppressors and oncogenes,
which have abnormal activities in human cancers. Two tumor
suppressors, p53 and Rb, have been shown to be inactive in the
vast majority of cancers. Their inactivation impairs cell cycle arrest
and apoptosis in response to cell damage. On the other hand, the
enhanced activities of oncogenes, such as receptor tyrosine kinases,
among them the IGF1 receptor, induce higher proliferation rates
and resistance to apoptotic stimuli. Much less effort has been
devoted to characterizing the initial steps of transformation. This is
mostly due to the lack of a cell system that encompasses the
continuum from the normal cell through full transformation.
When comparisons are made, they refer to the fully-transformed
tumor cell in comparison to its normal untransformed counterpart.
Human Papilloma virus, primarily types 16 (HPV16) and 18
(HPV18), are considered to be the causative agents for cervical
cancer and other anogenital lesions [1]. Infection induces
immortalization of cells, mainly as a result of activation of two
viral genes: E6 and E7. The E6 protein targets p53 for
proteasomal degradation, and E7 targets Rb for proteasomal
degradation [2–6]. Thus the E6 and E7 proteins interfere with cell
cycle control and apoptosis, and induce genomic instability in cells
[7]. HPV infection is responsible for cell immortalization, but full
transformation and tumor formation occur only years after
infection. During the period between infection and cancer
development, the cells accumulate mutations, which eventually
cause full transformation.
In this study we monitor changes in the early stages of
transformation, before cancer development. We have previously
suggested that transformed cells are more sensitive to stress, which
may partially account for their enhanced sensitivity to cytotoxic
agents [8,9]. In that study, we compared immortalized NIH3T3
cells to immortalized NIH 3T3 cells expressing oncogenes. In the
current study we have monitored the progressive sensitization to
stress upon the immortalization of normal cells and during the
initial steps of transformation, characterizing the changes in the
pre-malignant stage. Using an in-vitro cellular model system for
the development of cervical cancer, we have correlated the gradual
development of sensitivity to stress with the degree of cell
transformation. We examined HPV16-immortalized keratinocytes
extensively passaged in vitro, HF1 cells, comparing cells from early
and late passages. In late passages cells gain higher proliferation
rate and acquire the ability to form colonies in soft agar, but still
do not form tumors in nude mice, therefore have not reached full
transformation. Using this model of progressive cellular trans-
formation, we could compare immortalized cells from various
stages with their normal counterpart, namely, uninfected human
keratinocytes. When comparing normal keratinocytes to cells in
early passage (,60 doublings) after HPV16 transfection, we are
monitoring early events caused by the expression of HPV16 genes.
The differences between late passages (,1000 doublings) and early
passages most likely result from additional genetic and epigenetic
changes in these cells. We find that sensitivity to serum starvation
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passages. Moreover, as transformation proceeds in our model,
there is a reduction in the activity of key anti-apoptotic proteins,
PKB/Akt, Erk, Jnk and p38, and increased activation of p53 upon
stress. During starvation the transformed cells become dependent
on IGF1, which activates the above mentioned kinases, and
inhibits p53. Treatment with IGF1 rescues the cells via activation
of PKB/Akt and Jnk, and through them, inhibition of p53
induction. Similar results were obtained using an independent line
of HPV16-immortalized keratinocytes, HPKII cells, but not with
the fully transformed SiHa line. Sensitivity to stress correlates with
high induction of p53 activity, which is reduced with IGF1
treatment and activation of PKB/Akt. We conclude that during
early stages of cellular transformation, cells gain higher pro-
liferation rate, which occurs concurrently with higher activation of
p53 and a decrease in cell robustness.
METHODS
Experimental Procedures
Materials Cell culture reagents were purchased as follows:
DMEM, HAM/F12, RPMI and antibiotics from Biological
Industries Israel Beit Ha’emek Ltd.; FBS from Gibco BRL; EGF
from Peprotech Inc.; insulin, T3, transferrin, cholera toxin and
hydrocortisone from Sigma. Signal transduction inhibitors were
purchased as follows: Akt inhibitor V (triciribine), PD98059,
SP600125, SB203580, U0126 from Calbiochem; Cisplatin was
kindly received from Hadassah Hospital; Growth factors were
purchased as follows: IGF1, EGF and LPA from Sigma and NRG
from R&D Systems.
Cell culture
Primary keratinocytes and HF1 cells were grown in keratinocyte
growth medium (67% DMEM, 23% HAM/F12, 10% FBS, 5 mg/
ml insulin, 2 nM T3, 5 mg/ml transferrin, 0.4 mg/ml hydrocor-
tisone, 0.1 nM cholera toxin, 10 ng/ml EGF and antibiotics).
Primary keratinocytes were taken from small biopsy specimens
from control healthy donors. Cultures were kindly provided to us
regularly by Professor H. Ben-Bassat (Hadassah University
Hospital, Jerusalem, Israel). Primary keratinocytes from second
or third passage were used in the experiments reported here. HF1
cells were produced by transfection of the whole HPV16 genome
to human foreskin keratinocytes [10,11]. HF1 cells from various
passages were also obtained from Professor H. Ben-Bassat. Early
HF1 cells are ,60 doublings after HPV16 transfection. Late HF1
cells are ,1000 passages after transfection.
HPKII cells were kindly provided to us by Professor M. Duerst
(Friedrich-Schiller-Universita ¨t, Jena, Germany). HPKII cells were
grown in DMEM (low glucose) containing 10% FBS and
antibiotics. HPKII cells were generated by transfection of
HPV16 genome into human foreskin keratinocytes [12,13] . Early
HPKII cells are ,70 doublings after transfection, and late HPKII
cells are ,300 doublings after transfection.
SiHa cells were kindly provided to us by Professor S.
Rosenbaum-Mitrani (Hadassah Hospital, Jerusalem, Israel). SiHa
cells were grown in RPMI containing 10% FBS and antibiotics.
Methylene Blue assay
Primary keratinocytes, early HF1 cells and late HF1 cells
were plated in 96-well plates at a density of 2500 cells per plate.
Every 24 h a representative plate was fixed with 0.5% gluter-
aldehyde. Methylene blue assay was performed as described
elsewhere [10].
Soft agar assay
Primarykeratinocytes,earlyHF1cells andlateHF1cells were plated
in agar at a density of 5000 cells per well in a 96-well plate in growth
medium containing 0.3% agar (50 ml per well), on top of a layer of
growth medium containing 1% agar (100 ml per well). 50 mlo f
growth medium were added on top of the agar. Two weeks after
plating, the cells were stained with 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-tetrazolium bromide (MTT; Sigma) and photographed.
Cell cycle analysis
HF1 cells, HPKII cells and SiHa cells were plated in 6-well plates
at a concentration of 1.5610
5 cells per well. Primary keratinocytes
were plated in 6-well plates at a concentration of 2.5610
5 cells per
well. Cells were grown in starvation medium (75% DMEM, 25%
F12 and antibiotics) or exposed to 20 mM CDDP in the presence
or absence of IGF1, growth factors or inhibitors, as indicated in
each experiment. After 48 h cells were harvested and fixed with
methanol. Fixed cells were rehydrated with PBS, treated with
RNase A (5 mg/ml) and stained with propidium iodide (25 mg/
ml). Cell cycle analysis was performed by flow cytometry.
Immuno-blotting
Primary keratinocytes, HF1, HPKII and SiHa cells were plated in
6-well plates as indicated above. 48 h after plating, cells were
washed and grown in starvation medium (75% DMEM, 25%
HAM/F12 and antibiotics). Where indicated, the cells were
stimulated with 50 ng/ml IGF1 for the whole 24 h starvation
period or for the last 10 min of starvation. 24 h after initiation of
starvation, cells were lysed in sample buffer. Equal amounts of
protein from each sample were resolved by PAGE and analyzed
by western blot. The following antibodies were used: Monoclonal
anti-E7, a kind gift from Dr. Martin Muller, DKFZ, Heidelberg,
Germany; anti-PARP, anti-phospho-Akt(T308), anti-phospho-
JNK(T183,Y185), anti-phospho-p38(T180,Y182) from Cell Sig-
naling Technology; anti-phospho-Erk(T183,Y185), anti-Tubulin
from Sigma; anti-Rb from Pharmingen; anti-Akt1/2, anti-Erk2,
anti-JNK, anti-p38 and anti-p53(FL393) from Santa Cruz; anti-
beta-Catenin from BD Transduction.
Immuno-staining
HF1 cells and primary keratinocytes were plated on coverslips in
24-well plates at a concentration of 3610
4 cells/well and 5610
4
cells/well respectively. 48 h after plating, cells were washed and
grown with starvation medium for 12 h, followed by fixation with
3% paraformaldehyde containing 0.5% TritonX100 for 30 sec
and with 3% paraformaldehyde for 30 min. Cells were stained
with anti-cytochrome C antibody (Santa Cruz).
Real-time PCR
Primary keratinocytes, HF1, HPKII and SiHa cells were plated in
6-well plates as indicated above. Where indicated, cells were serum
starved, treated with IGF1 or treated with IGF1 plus 10 mM Akt
inhibitor V or 10 mM SP600125. RNA was isolated from cells with
the RNeasy-RNA isolation kit (Qiagen), and subjected to reverse-
transcription with random hexamers using ImpromII reverse-
transcriptase (Promega) according to the manufacturer’s direc-
tions. Real-time PCR was performed with the Power Sybr-Green
PCR mix, according to the manufacturer’s directions. NOXA
primers used were: fwd: 59GCAGAGCTGGAAGTCGAGTGT,
rev: 59AAGTTTCTGCCGGAAGTTCAG HPRT primers used
were: fwd: 59TGACACTGGCAAAACAATGCA, rev: 59GG-
TCCTTTTCACCAGCAAGCT.
Keratinocyte Transformation
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Keratinocytes and HF1 cells were grown in 6-well plates as
indicated above. 48 h after plating cells were transfected with
LipofectAmine Plus reagent (Invitrogen) according to the manu-
facturer’s directions. Cells were transfected with pRGC-luciferase
or pRGC(mutant)-luciferase encoding firefly-luciferase under the
regulation of a promoter containing 17 repeats of the p53 response
element or of a mutant response element respectively. Both
constructs were kindly received from Professor M. Oren
(Weizmann Institute of Science, Rehovot, Israel). Cells were co-
transfected with a CMV-renilla construct for normalization to
transfection efficiency. 24 h after transfection cells were serum
starved, and 24 h afterwards cells were lysed with passive lysis
buffer (Promega). Firefly and renilla luciferase assays were
performed with a dual luciferase assay kit (Promega).
RESULTS
Initial transformation is characterized by accelerated
growth and anchorage-independent growth
In order to understand the early events that occur during
transformation, we studied an in vitro model of keratinocyte
transformation with HPV16. We compared primary human
keratinocytes to HPV16 transformed cells, HF1 cells, from early
stages (,60 doublings post transfection) and late stages (,1000
doublings post transfection). As a first step in cell characterization
we monitored the growth rates of the various cell types by
methylene blue assay. As transformation proceeded growth was
accelerated and doubling time was reduced from .24 h in the
primary keratinocytes to 22 h in early HF1 and 16 h in late HF1
cells (Figure 1A). Additionally, early in transformation cells gained
the ability to survive and grow in soft agar. Primary keratinocytes,
early and late HF1 cells were plated in soft agar and grown for two
weeks, followed by staining of live cells with MTT. In contrast to
the primary keratinocytes, immortalized HF1 cells survived in soft
agar. Early HF1 cells survived, but did not proliferate and did not
form colonies in soft agar, and are therefore seen as MTT-stained
single cells. In contrast, late HF1 cells formed both micro-colonies
and more rarely large colonies in soft agar (Figure 1B). In-
troduction of late HF1 cells into nude mice did not result in tumor
formation, so they are not considered fully transformed cells.
Therefore higher proliferation rate and growth in soft agar are first
steps in cancer progression to full malignant phenotype.
Sensitivity to stress signals increases in the course of
transformation
In order to investigate whether early transformation induces
higher resistance to apoptotic stimuli, we tested the sensitivity of
the different cultures to serum starvation. Cells were stained with
propidium iodide and submitted to FACS analysis. The sub-G1
fraction was quantified as a measure of cell death. Serum
deprivation for 48 h did not induce any increase in cell death of
the primary keratinocytes, but rather slightly reduced it
(Figure 2A). In contrast, serum withdrawal induced 22% death
in early HF1 cells, and 32% death in the more transformed, late
HF1 cells. Western blot analysis of cells after 24 h serum starvation
and reaction of the blots with anti-PARP antibody showed that
cells died via apoptosis. In primary keratinocytes, which were not
Figure 1. Early transformation induces higher growth rate and enables growth in soft agar. A. Methylene blue assay for cell growth. Primary
keratinocytes, early and late HF1 cells were plated at equal densities and grown for three days. Each day a representative plate was fixed. All plates
were stained with methylene blue as described elsewhere [10]. Error bars represent standard deviations of triplicates. Similar results were obtained in
at least 5 independent experiments. B. Cells were plated at equal densities in soft agar. Two weeks later, live cells were stained with MTT. The figure
shows two fields of each cell type (Bar=200 mm). Similar results were obtained in three independent experiments.
doi:10.1371/journal.pone.0000605.g001
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cleaved upon starvation of early HF1 cells and even more
dramatically in late HF1 cells (Figure 2B). We also immuno-
stained cytochrome C to monitor its release from the mitochon-
dria. We already detected cytochrome C release after 12 h of
starvation in late HF1 cells, but not in primary keratinocytes or
early HF1 cells, which are more resistant to the stress (Figure 2C).
In order to see whether the increased sensitivity to stress was
a more general phenomenon or restricted to starvation, we
exposed the cells to the DNA damaging agent, Cisplatin. Cisplatin
treatment induced cell death in all three cell types and again,
sensitivity increased with transformation (Figure 2D). Treatment
with 20 mM Cisplatin for 48 h induced 35% death of normal
keratinocytes, 50% death of early HF1 and ,80% death of late
HF1 cells.
These experiments show a clear increase in sensitivity to stress
as a result of cell immortalization and in vitro passaging. Stress
induced faster activation of mitochondrial apoptosis, which results
in caspase activation and DNA fragmentation. The fact that only
HF1 cells, but not the primary keratinocytes, were sensitive to
serum starvation provided a convenient, clear-cut system for
further analysis. We therefore concentrated our studies on the
response of HF1 cells to serum starvation.
The involvement of p53 in Rb in the response to
stress
It has been shown that expression of the E6 or E7 genes of HPV
often increases stress sensitivity [14–17]. Since transformation in
our system initiated with HPV16 transfection, we examined the
expression of the viral genes and their targets, p53 and Rb, to see
whether the increased stress sensitivity could be attributed to their
expression. Since there are no efficient antibodies against E6, and
the E6 and E7 genes are co-regulated, E7 expression is a valid
indicator for viral gene expression. The E7 protein was very highly
expressed in early HF1 cells, and its level was markedly reduced in
late HF1 cells (Figure 3A). Our results suggest that the viral
proteins trigger the initiation of transformation, but their effects
are reduced in later stages. In agreement with the expression of
E7, the Rb protein level was reduced in early HF1 cells, but
elevated in late HF1 cells. Thus Rb expression did not correlate
with sensitivity to stress.
The level of p53 was gradually reduced upon progression from
primary keratinocytes, through early to late HF1 cells (Figure 3A).
P53 appeared in the western blot as three bands; the lower band
was intensified in late HF1 cells, but the other two almost
disappeared. Sequencing of p53 cDNA in these cells revealed no
mutation or deletion in the p53 coding sequence (data not shown),
so the three bands appear to represent wt p53 with different post-
translational modifications. The p53 protein is very highly
regulated, mainly via phosphorylation and proteasomal degrada-
tion [18]. Reaction with several antibodies that recognize different
phosphorylated forms of p53 did not shed light on the protein’s
activity in the various cell types (not shown). In order to compare
p53 activity in the three cell types under normal growth conditions
we looked at the expression of p53 targets. Table 1 shows
expression levels of six known p53 targets, which were obtained
from Affymetrix micro-arrays (Kravchenko-Balasha, in prepara-
tion). There was a gradual decrease in the expression of GADD45,
p21, MMP2 and TGFalpha from the primary keratinocytes
through early HF1 cells, to late HF1 cells. NOXA and IGFBP3
expression rose slightly in early HF1 cells, but was dramatically
reduced in the later stage. GAPDH expression is given as an
internal control for constant mRNA expression. NOXA is a known
Figure 2. Transformed cells are more sensitive to stress than normal
primary keratinocytes. A. Cells were serum starved (white) or
untreated (black) for 48 h. After treatment, cells were fixed, stained
with propidium iodide and analyzed by flow cytometry. The sub-G1
fraction of the cells was quantified as a measure of cell death. Error bars
represent the standard error of three independent experiments. B.
Representative western blot of cells after 24 h starvation. PARP
cleavage reflects caspase activation during apoptosis. Tubulin serves
as a loading control. C. Immuno-staining of cytochrome C after 12 h
serum starvation (Bar=15 mm). D. Cells were treated with 20 mM
Cisplatin for 48 h, fixed and analyzed as in A. Error bars represent the
standard error of three independent experiments.
doi:10.1371/journal.pone.0000605.g002
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validated the micro-array results by real-time PCR of this gene
and normalized NOXA expression to the expression of the house-
keeping gene hypoxanthine phosphoribosyltransferase (HPRT).
Indeed, NOXA RNA levels rose slightly in early HF1 cells, but
was markedly reduced in late HF1 cells (Figure 3B). Integration of
the micro-array data and real-time PCR results show a marked
reduction in its basal activity in late HF1 cells, but not in early
HF1 cells.
Due to the possible involvement of p53 in the stress response, we
examined the changes in p53 activity after serum starvation. We
used NOXA as a marker for pro-apoptotic p53 activity.
Surprisingly, real-time PCR of NOXA showed that although the
basal NOXA RNA level was reduced, induction in response to
starvation increased as transformation proceeded (Figure 3C). We
confirmed these results with a reporter assay, where firefly-
luciferase (FFL) was expressed under the control of p53-response
elements, with mutant response elements serving as controls.
Differences in transfection efficiency were eliminated by normal-
ization to renilla-luciferase under the control of the CMV-
promoter. FFL activity was measured under basal growth
conditions and following 24 h starvation. FFL expression was
not induced by starvation in the primary keratinocytes, but was
induced slightly in early HF1 cells, and reached 5-fold induction in
Figure 3. P53 and Rb under basal conditions and during starvation. A. Representative western blots of whole cell lysates of primary keratinocytes,
early and late HF1 cells under basal growth conditions. Blots show the status of HPV16 E7 protein, Rb and p53. Graphs show quantification of these
blots. Protein densities were normalized to the densities of the bands in early HF1 cells. Error bars represent the standard deviations of three
independent experiments. Tubulin serves as a loading control. B. Real-time PCR for NOXA expression under basal conditions. RNA was isolated from
untreated cells and subjected to reverse-transcription followed by real-time PCR with specific primers for NOXA and HPRT as control. NOXA results
were normalized to the HPRT results. Error bars represent the standard errors of three independent experiments. C. Real-time PCR for NOXA
expression in starved vs. untreated cells. Cells were serum starved for 24 h, RNA was isolated, reverse-transcribed and subjected to real-time PCR as in
B. Fold induction represents results of starved cells vs. non-starved cells. Error bars represent the standard error of three independent experiments. D.
Reporter assay for p53 activity in untreated and serum starved cells. Cells were transfected with firefly-luciferase (FFL), either under the controlo f1 7
p53-response elements, or under the control of mutant response elements as control. For transfection control cells were co-transfected with renilla-
luciferase under the control of CMV promoter. 24 h after transfection cell medium was replaced with normal growth medium or starvation medium,
for another 24 h. Cells were lysed and subjected to luminisence assay. Error bars represent standard errors of four independent experiments.
doi:10.1371/journal.pone.0000605.g003
Table 1. Expression of p53 targets
......................................................................
GENE Primary ker Early HF1 Late HF1
GADD45a 160.035 0.8660.074 0.2960.112
P21 160.030 0.7760.151 0.1360.151
NOXA 160.017 1.4760.288 0.1360.012
MMP2 160.45 0.3660.092 0.4660.044
IGFBP3 160.042 1.2560.120 0.6360.277
TGFalpha 160.183 0.6060.230 0.1460.051
GAPDH 160.114 1.0860.142 1.1260.100
Table1: Expression of p53 targets according to Affymetrix Human Genome
U133A microarrays. Results were normalized to the expression in the primary
keratinocytes. GAPDH expression is given as internal control. Standard
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the reporter assay, we saw a direct correlation between the
stimulation of p53 pro-apoptotic activity during serum starvation
and the induction of apoptosis.
Anti-apoptotic signaling is reduced in early stages
of transformation
Given the increased apoptosis in late HF1 cells and increased
activation of p53 under starvation, we examined the activity of key
anti-apoptotic signaling pathways in the cells. The phosphoryla-
tion of PKB/Akt and Erk was gradually reduced as a function of
the degree of transformation (Figure 4A). We also examined the
status of the stress kinases Jnk and p38, which act as pro- or anti-
apoptotic proteins in different conditions and cellular systems.
Phosphorylation of both Jnk and p38 was also reduced with
transformation (Figure 4A). Total protein levels of PKB/Akt, Erk,
Jnk and p38 remained almost unchanged.
We investigated the response of the PKB/Akt, Erk, Jnk and p38
proteins to serum starvation. Twenty-four hour starvation induced
a reduction in PKB/Akt phosphorylation most dramatically in the
primary keratinocytes and in early HF1 cells, with no effect on the
level of PKB/Akt protein (Figure 4B). Even after starvation, the
phosphorylated PKB/Akt level was higher in the primary
keratinocytes than in unstarved late HF1 cells and could still
transmit anti-apoptotic signals. Less profound effects were seen on
the phosphorylation of Erk, Jnk and p38 in response to starvation
(Figure 4B). We showed that in late HF1 cells basal activity of the
anti-apoptotic proteins: PKB/Akt, Erk, Jnk and p38 are very low
compared to the normal counterparts. Their activities are not
induced upon serum starvation, therefore do not enable survival
under stress.
IGF1 rescues HF1 cells from serum starvation
We investigated whether sensitivity to stress results from the low
anti-apoptotic activity seen in late HF1 cells, and whether these
signaling changes are responsible for p53 activation. Due to very
low transfection efficiency, and high toxicity of the transfection
reagents, we could not introduce dominant-negative constructs or
siRNA into the cells. We therefore used a pharmacological
approach. First we looked for factors that would rescue the cells
from apoptosis when added to the starvation medium and
examined the effects of selective pharmacological agents on their
action. HF1 cells were starved for 48 h in the presence of insulin-like
growth factor 1 (IGF1), epidermal growth factor (EGF), neuregulin
(NRG), or lysophosphatidic acid (LPA). The first three are major
factors involved in epithelial cell growth and survival [20–22], and
stimulate known anti-apoptotic pathways. LPA is a major compo-
nent of serum, and is very often responsible for its effects [23]. We
examined cell death by propidium iodide staining and quantification
of the sub-G1 fraction of the cell cycle. All four factors reduced the
fraction of apoptotic cells. Early HF1 cells were rescued completely
by both IGF1 and EGF, while NRG and LPA had smaller effects.
Late HF1 cells were rescued completely by IGF1, while EGF, NRG
and LPA had weaker effects (Figure 5A). Clearly IGF1 was the most
potent factor for the rescue from starvation in both cell types.
Furthermore, as the cells became more transformed, the significance
of the other factors investigated was reduced.
Indeed treatment of HF1 cells with 50 ng/ml IGF1, during
starvation, completely rescued cells from apoptosis. IGF1
treatment reduced the sub-G1 fraction of cells to the basal state
in both early and late HF1 cells (Figure 5B). Cell cycle analysis
after 48 h starvation with or without IGF1 showed that starvation
increased the sub-G1 fraction, accompanied by a reduction in the
fraction of cells in the S and G2/M phases, mainly in late HF1
cells. Rescue by IGF1 reduced the sub-G1 fraction in both cell
types, accompanied by an increase in the fraction of cells in G1.
IGF1 did not change the fraction of cells in S phase and had only
a minor effect on cells in G2/M. Under these conditions, IGF1
transmitted a strong anti-apoptotic signal for survival, but did not
suffice for cell cycle progression. Thus the cells became dependent
on a single agent, IGF1, for survival under serum starvation.
IGF1 rescues HF1 cells via activation of PKB/Akt and
JNK and inactivation of p53
IGF1 is an upstream regulator of: PKB/Akt, Erk, Jnk, p38 and
p53 [21,24–28]. We therefore explored which of these proteins
mediate survival of HF1 cells under stress. To determine which
pathway downstream of the IGF1R is responsible for the rescuing
activity of IGF1, we first studied which signaling proteins are
stimulated by IGF1. We serum starved the cells for 24 h and
added IGF1 either during the whole starvation period or during
the last 10 min before cell lysis (Figure 5C). We looked at the
phosphorylation of the above-mentioned IGF1R targets: PKB/Akt,
Erk, Jnkand p38. PKB/Aktwasphosphorylated byIGF1, after both
short and long stimulations. PKB/Akt phosphorylation was very
high following the short stimulation, but even after 24 h stimulation
thephosphorylationlevelofPKB/Aktwasat leastashighasthelevel
in the presence of 10% serum. Erk, Jnk and p38 were activated only
after short stimulation with IGF1, but might nevertheless have
initiated long-term effects. P53 activity, as detected by NOXA
expression was down-regulated by IGF1 (Figure 5D).
We next examined the effects of specific kinase inhibitors on
IGF1-mediated rescue from starvation. In early HF1 cells,
treatment with the PKB/Akt inhibitor or the JNK inhibitor
SP600125, abrogated the IGF1 effect completely (Figure 6A),
suggesting that PKB/Akt and Jnk are responsible for the IGF1R-
mediated rescue. In late HF1 cells, again PKB/Akt inhibition and
Jnk inhibition showed the strongest effects, but only partially
reversed IGF1 rescue. In contrast, the Erk inhibitor PD98059 and
the p38 inhibitor SB203580 had no effect on cell survival. Thus
IGF1 induced its anti-apoptotic activity mainly via activation of
PKB/Akt and Jnk.
We then investigated whether the effect of IGF1 on p53 is
mediated through PKB/Akt and Jnk. We serum starved the cells
in the presence of IGF1 and the PKB/Akt inhibitor or the Jnk
inhibitor SP600125. Under these conditions, p53 activity (as
judged by real-time PCR of NOXA) was markedly elevated
compared to the IGF1 treated cells (Figure 6B).
Loss of robustness and dependence on IGF1 is
detected also in HPKII cells, HPV16 immortalized
keratinocytes, but not in the cervical cancer cell-line,
SiHa
We investigated another system of HPV16 immortalized keratino-
cytes, HPKII cells from early stages (,70 doublings) and late stages
(,300 doublings). HPKII cells from early and late passages
underwent ,20% apoptosis in response to 48 h of starvation
(Figure 7A). Like HF1 cells, HPKII cells were rescued from serum
starvation by IGF1. Early HPKII cells were fully rescued by IGF1,
while in late HPKII cells, IGF1 induced 60% rescue (Figure 7A).
Furthermore, we found a clear correlation between induction of
apoptosis and p53 induction. In both early and late passage HPKII
cells, p53 was induced ,3.5 fold in response to 24 h starvation, and
IGF1reduced the induction ofp53 (Figure7B). In earlyHPKII cells,
where IGF1 fully rescued cells from starvation, IGF1 reduced p53
Keratinocyte Transformation
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60%rescuefromstarvation,itreducedp53by40%.Thus,starvation
effects both HPKII and HF1 cells in a similar manner, both with
regard to their p53 response and to the attenuating effects of IGF1.
Unlike HF1 cells, which showed a progressive decrease in
phosphorylation levels of the anti-apoptotic proteins PKB/Akt,
Erk, Jnk and p38, these were elevated in early HPKII cells, and
were higher in late HPKII cells (Figure 7C). Like HF1 cells,
Figure 4. Anti apoptotic signaling is reduced both under basal conditions and under stress. A. Representative western blots of PKB/Akt, Erk, Jnk
and p38 in their phosphorylated and non-phosphorylated forms under normal growth conditions. Blots were reacted with the indicated antibodies as
described in ‘‘Experimental Procedures’’. Tubulin serves as a loading control. Graph shows quantification of phosphorylated protein normalized to the
total protein level. Results were normalized to the levels in early HF1 cells. Error bars are standard errors of three independent experiments. B.
Representative western blots of cells under normal growth conditions and after 24 h starvation. Blots were reacted as in A. Graphs show
quantification of protein phosphorylation level vs. total protein level. Results were normalized to the protein level in untreated keratinocytes. Error
bars are standard errors of three independent experiments.
doi:10.1371/journal.pone.0000605.g004
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PLoS ONE | www.plosone.org 7 July 2007 | Issue 7 | e605Figure 5. IGF1 rescues HF1 cells from serum starvation, activates PKB/Akt, Erk, Jnk and p38, and inactivates p53. A. Early and late HF1 cells were
serum starved for 48 h in the presence of 50 ng/ml IGF1, 30 ng/ml EGF, 30 ng/ml NRG or 10 mM LPA. Stimulated cells were compared to starved and
non-starved (FBS) cells. Cells were fixed, stained with propidium iodide and analyzed by flow cytometry. The sub-G1 fraction was quantified as
a measure of the apoptotic cells. Error bars represent the standard error of at least three independent experiments. B. Cell cycle analysis of non-
starved and starved cells in the presence or absence of IGF1. After 48 h treatment cells were fixed, stained with propidium iodide and analyzed by
flow cytometry. Error bars represent the standard error of at least three independent experiments. C. Representative western blots of cells after IGF1
stimulation. HF1 cells were starved for 24 h and stimulated with 50 ng/ml IGF for the last 10 minutes or the whole 24 h of treatment. Stimulated cells
were compared to starved and non-starved cells. Blots were reacted with the indicated antibodies. On the right, the densities of the phosphorylated
proteins were normalized to the levels of the ‘‘total’’ proteins (phosphorylated and non-phosphorylated), where the starved cells were assigned
a value of 1. Tubulin serves as a loading control. Error bars are standard errors of three independent experiments. D. Real-time PCR results of NOXA
expression vs. HPRT expression in cells under normal condition or under starvation with or without IGF1. Results were normalized to the results from
untreated controls of each cell. Error bars are standard errors of three independent experiments.
doi:10.1371/journal.pone.0000605.g005
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these proteins, mainly in late HPKII cells.
In order to find the anti-apoptotic protein through which IGF1
rescues HPKII cells, we starved the cells in the presence of IGF1
and in the presence kinase inhibitors. Inhibition of Akt totally
reversed the rescue effect of IGF1 in late HPKII cells, whereas it
only partially reversed the effect of IGF1 in early HPKII cells
(Figure 7D). The MEK1 inhibitor, U0126, Jnk inhibitor,
SP600125 and p38 inhibitor, SB203580 had weaker effects on
cell death. Thus rescue of HPKII cells depends mainly on PKB/
Akt activation whereas rescue of HF1 cells requires both PKB/Akt
and Jnk.
Investigation of the cervical cancer cell line SiHa showed that
unlike the HPV16-immortalized cells, fully transformed cells were
not sensitive to serum starvation (Figure 7A), and p53 was not
activated under these conditions (Figure 7B). But, like in late HF1
cells, in SiHa cells anti-apoptotic signals of PKB/Akt, Erk, Jnk and
p38 were very low under normal growth conditions and upon
starvation (Figure 7C).
These data show that sensitivity to stress increases due to
activation of p53 in two independent cell lines in which
transformation was initiated with HPV16. The early transformed
cells depend largely or exclusively on PKB/Akt activity, which
inhibits p53 induction, for their survival upon starvation. Pre-
sumably, in HPKII cells (as in HF1 cells), the decrease in anti-
apoptotic activity upon stress enables p53 induction and apoptosis.
In contrast, in SiHa cells, where the activities of these enzymes are
even lower than in starved HPKII cells, p53 is not induced and
cells survive upon starvation, most likely due to the presence of
other anti-apoptotic networks, which have emerged on the path to
full transformation.
DISCUSSION
In an attempt to understand the long process that leads to HPV16-
mediated transformation, we have compared primary human
keratinocytes and HPV16-immortalized keratinocytes, HF1 and
HPKII cells, at various stages of in vitro transformation.
Presumably, most of the differences between primary keratinocytes
and early passage HF1 and HPKII cells are related to the
introduction of the HPV16 genome, and the differences between
early passage and late passage HF1 and HPKII cells, result from
prolonged passaging in vitro. As the HF1 cells became pro-
gressively more transformed their growth rate accelerated and they
gained the ability to survive in soft agar (Figure 1). Late passage
HF1 and HPKII cells can be considered to be pre-cancerous.
Although they did not form detectable tumors in nude mice,
HPKII cells did form benign cysts [12,13]. During the course of
transformation, the HPV16-immortalized cells became more
prone to cell death upon stress (Figure 2,7). These results are
supported by previous findings showing that transfection of cells
with the HPV16 E6 gene sensitizes cells to genotoxic stress [15].
E6 expression impairs nucleotide excision repair, reducing the
cells’ capability to recover from DNA damage [14], and E7
expression reduces survival after UV irradiation [16]. Impairment
of cell-cycle control due to Rb and p53 down-regulation would be
expected to result in cell death in response to environmental stress.
Indeed, early HF1 cells highly express HPV16 genes (Figure 3A)
and show higher sensitivity to both serum starvation and Cisplatin
compared to normal keratinocytes. In the more transformed late
HF1 cells, however, HPV16 gene expression is reduced; therefore
their expression cannot be the immediate cause of the even greater
sensitivity in these stages.
The interplay between p53 and Rb is very complex and involves
the E2F transcription factor family. Rb binds and inhibits the
E2Fs, which stabilize and activate p53 by several mechanisms
[29]. First, E2F upregulates p14ARF, which reduces Mdm2-
induced degradation of p53 [29]. Moreover, it induces transcrip-
tion of ATM, which phosphorylates and stabilizes p53 [30], and
can also upregulate the p53 binding partners, ASPP1/2, JMY,
TP53INP1, which elevate p53 pro-apoptotic activity [31]. Here
we have shown high E7 expression and low Rb level in early HF1
cells, implying high E2F activity. E2F activation of p53 may
counteract E6 activity, explaining why p53 was only slightly
affected in early HF1 cells. In contrast, in late HF1 cells we found
high Rb levels, which may have led to lower E2F activity, and
hence to the very low basal activity of p53 in these cells.
The reduction in HPV16 gene expression in late HF1 cells is
most probably caused by changes in cellular signaling components.
HPV16 gene expression has been shown to be controlled by
cellular factors such as AP1, NF1 and glucocorticoids, which bind
the P97 HPV promoter [32,33]. We show that in late HF1 cells
MAP kinase activity is decreased compared to early HF1 cells
(Figure 4A). Reduced MAP kinase activity is expected to cause
reduced AP1 activity, leading to the observed reduction in HPV
expression, and the rise in Rb level in late HF1 cells. Indeed,
results from our laboratory show AP1 activity is markedly reduced
in late HF1 cells (Kravchenko-Balasha et al, in preparation).
Changes in Rb level during cervical cancer development have
been documented by Salcedo et al [34]. These authors showed
Figure 6. PKB/Akt and Jnk mediate IGF1 rescue of cells and the
inactivation of p53 by IGF1. A. Cells were starved for 48 h in the
presence of IGF1 and treated with either 10 mM Akt inhibitor, 50 mM
PD98059, 10 mM SP600125 or 1 mM SB203580. Control cells were non-
starved and starved cells with or without IGF1 treatment. Cells were
fixed, stained with propidium iodide and analyzed by flow cytometry.
The sub-G1 fraction represents cell death. Error bars represent standard
error of three independent experiments. B. Real-time PCR results of
NOXA vs. HPRT of cells under normal conditions or during starvation
with or without IGF1 in the presence or absence of 10 mM Akt inhibitor
or 10 mM SP600125. Results were normalized to the results from




PLoS ONE | www.plosone.org 9 July 2007 | Issue 7 | e605Figure 7. HPKII cells, but not SiHa cells, are sensitive to starvation, due to p53 induction in the absence of IGF1. A. Cells were starved for 48 h with
or without IGF1. Cells were fixed, stained with propidium iodide and analyzed by flow cytometry. The subG1 fraction represents cell death. B. Real-
time PCR results of NOXA vs. HPRT of cells under normal conditions or during starvation with or without IGF1. C. Representative western blots of PKB/
Akt, Erk, Jnk and p38 in their phosphorylated and non-phosphorylated forms under normal growth conditions and upon 24 h starvation. Reaction
with anti-beta-Catenin serves as a loading control. Blots were reacted with the indicated antibodies as described in ‘‘Experimental Procedures’’. Graph
shows quantification of phosphorylated protein normalized to the total protein level. Results were normalized to the levels in untreated SiHa cells.
Error bars are standard errors of three independent experiments. D. Cells were starved for 48 h with or without IGF1 and treated with either 10 mM
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epithelium, but rose in squamous intraepithelial lesions (SIL),
a pre-cancerous state. Rb expression was then reduced in invasive
cervical cancer. Possibly late HF1 cells represent a stage similar to
SIL, an intermediate stage of transformation.
The amount of p53 was only slightly reduced with trans-
formation, but there was a marked difference in its activity and
electrophoretic mobility, suggesting different post-translational
modifications of the protein. The activity of p53 was markedly
reduced in late HF1, cells as assessed by the transcription of its
targets. We examined p53 induction both by real-time PCR of
NOXA and by reporter assay. Surprisingly, we found that p53
induction in response to stress increased with transformation, even
though basal p53 activity was very low in the more transformed
cells. While p53 activity was not induced at all by stress in primary
keratinocytes, and was only slightly induced in early HF1 cells,
there was a 5–7 fold induction in late HF1 cells (Figure 3C,D) and
3.5 fold induction in HPKII cells (Figure 7B). In fully transformed
SiHa cells, we detected no activation of p53 upon starvation,
neither was apoptosis induced. It has been shown that SiHa cells
have very high Stat3 activity [35], which may prevent p53
induction [36], and account for the resistance of SiHa cells to
stress. These cells also highly express the anti-apoptotic BH3
protein MCL1 [37]. Thus, it seems that SiHa cells represent the
transformed state beyond the addictive stage, when robustness has
been re-established. It has been reported that p53 can be activated
in these cells in response to adriamycin treatment, but not in
response to oxidative stress by hydrogen peroxide [38]. Pre-
sumably the differential response to various stresses and various
stress intensities, results in disparity in p53 activation, which leads
to differential cell fate.
Little is known about p53 induction in normal epithelial cells.
Girinsky et al [39] showed that p53 is highly induced in response
to stress in normal stromal cells, but they detected no induction in
normal epithelial cells. The reasons for these differences are still
unknown, but most probably reflect the robustness of the normal
keratinocyte. Perhaps, the lack of p53 activation in normal
epithelial cells increases their resistance to various external stresses,
and may be essential for epithelial tissue integrity.
The increased apoptosis in late HF1 cells, in conjunction with
the increase in stress-induced p53 pro-apoptotic activity, led us to
investigate anti-apoptotic signaling. We detected a decrease in the
activity of key anti-apoptotic signaling components in HF1 cells.
The phosphorylation of PKB/Akt and Erk, Jnk and p38 was
gradually reduced as a function of the degree of transformation
(Figure 4A), while total protein levels remained almost constant.
Other studies have shown high activities of Akt and Erk in fully
transformed cancer cells [40,41]. Many cancer models were
developed by introduction of active oncogenes into primary or
immortalized cells [42]. In these models it is expected that anti-
apoptotic proteins would be activated by the introduced oncogenes
even during early stages. In contrast, our model mimics the
physiological situation, in which normal cells are infected with
HPV16, and the cells replicate for years and accumulate
mutations. The phenomenon of decreased anti-apoptotic signaling
during cancer development is supported by our results from SiHa
cells, which show low activities of PKB/Akt, Erk, Jnk and p38. We
propose that reduced anti-apoptotic activities of the above-
mentioned proteins are a common feature in transformation,
where in both HF1 and HPKII PKB seems to play a key role,
where in the latter is more prominent.
During stress, anti-apoptotic proteins are often activated by
several autocrine pathways, and enable cell survival [43,44]. Full
blown cancer cells utilize growth factors such as IGF1 to overcome
stress or pro-apoptotic signals, by re-igniting the downstream
pathways. In HF1 cells, phosphorylation of PKB/Akt, Erk, Jnk
and p38 was reduced during serum starvation (Figure 4B). In
HPKII cells, although we did not detect a similar reduction in
anti-apoptotic activities under normal growth conditions, we did
see that the activities of PKB/Akt, Erk, Jnk and p38 are mostly
reduced upon starvation (Figure 7C). Nonetheless, the inactivation
of these growth-promoting anti-apoptotic proteins during starva-
tion did not enable survival of the transformed cells during stress.
Apparently, in late stage HF1 and HPKII cells we ‘‘capture’’ the
transformation process at a stage just prior to the onset of
autocrine activation characteristic of fully neoplastic cells. Namely
at this stage cells are hyper-sensitive to stress (see also ref. 9).
We found a correlation between p53 induction, decreased anti-
apoptotic signaling upon starvation and sensitivity to stress. To
confirm the connection between these factors we tried to activate
the anti-apoptotic proteins, or inactivate p53 in early and late HF1
cells, and reverse the effect. We were able to rescue the cells from
apoptosis by adding IGF1 to the starvation medium. As
transformation proceeds cell dependence on IGF1 increased.
Figure 5A shows that late HF1 cells are fully rescued only by
IGF1, while early HF1 cells could also be rescued by EGF,
implying that the late HF1 cells had become addicted to IGF1.
Cervical cancer cells have been shown to become dependent on
IGF1R activity for their growth and survival [45–47] . It has also
been shown that in early stages of transformation cells depend on
external IGF1, secreted from stromal cells, while fully transformed
cancer cells secrete IGF1, and their survival depends on this
autocrine pathway [43]. Here, IGF1 induced a strong anti-
apoptotic signal rather than a proliferative signal. IGF1 treatment
enabled cell survival during starvation, but did not enable cell
cycle progression in the absence of nutrients, and therefore
treatment resulted in arrest in G1 phase of the cell cycle. Thus, our
data suggest that the property of cancer cells being addicted to
a particular pathway [48] develops in the precancerous stage.
We found that PKB/Akt and Jnk activities were up-regulated
and p53 activity down-regulated by IGF1 (Figure 5D). Accord-
ingly, Inhibition of PKB/Akt or Jnk (Figure 6A) led to activation of
p53 (Figure 6B), and therefore abrogation of the IGF1 rescuing
activity. We conclude that during stress, low activity of PKB/Akt
and Jnk enables p53 activation and apoptosis in late HF1 cells.
The importance of PKB/Akt in mediating the rescue effect of
IGF1 was shown here also in HPKII cells.
IGF1 and EGF very often transmit their signal through similar
down-stream signaling pathways. One possible explanation for the
higher potency of IGF1 in the rescue of HF1 cells may come from
different levels of their receptors. Another explanation may come
from their effects on the IGF binding protein 3 (IGFBP3). It has
been shown that p53 induces transcription of IGFBP3 [49].
Moreover, IGFBP3 was induced by serum starvation, and
induction was inhibited by EGF [50]. In our system both EGF
and IGF1 may down-regulate p53, possibly leading to decreased
expression of IGFBP3. Exogenous IGF1, but not EGF might
surmount the low levels of IGFBP3, leading to rescue from
starvation.
In summary, using an in vitro model of keratinocyte trans-
formation by HPV16, we have shown that during the course of
transformation, cells develop increased sensitivity to stress, which
correlates with higher activation of p53 and reductions in the
activities of PKB/Akt, Erk, Jnk and p38 in HF1 cells. We show
that the low activities of PKB/Akt and Jnk are responsible for the
increased cell death of late HF1 cells, and that their low activities
during stress enable p53 induction and initiation of apoptosis,
when deprived of IGF1, and nutrients. The reduction in the anti-
Keratinocyte Transformation
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and results in more cell death. We show that as transformation
progresses cells become more dependent on IGF1 for their
survival. Normal epithelial tissue seems to be resistant to damaging
agents, most probably because of the robustness of the anti-
apoptotic network, and the quiescent p53. During transformation
normal tissue integrity and function are impaired, anti-apoptotic
signals are down-regulated, leading to hyper-activation of p53 and
increased cell death in response to stress. Similar results were
obtained with HPKII cells, which were developed independently.
Significantly, SiHa cells, which represent fully transformed
HPV16 infected cells, are robust and do not succumb to
starvation, most likely since they have acquired an anti-apoptotic
network in which Stat3 and MCL-1 may play a pivotal role
[35,37] . Our results suggest that on the path of HPV16 induced
transformation, cells acquire addiction to IGF1 but, when
progressing to the fully malignant phenotype, they overcome this
Achilles heel and re-establish robustness, characteristic of cancers
refractory to therapy.
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